FK506-Binding protein 12 modulates m-opioid receptor phosphorylation and protein kinase σ-dependent signaling by its direct interaction with the receptor

Molecular Pharmacology

Volumn 85, Issue 1, 2014, Pages 37-49

  Qiu, Yu ^a,b   Zhao, Wei ^b   Wang, Yan ^a   Xu, Jian Rong ^a   Huie, Eddie ^b   Jiang, Shan ^a   Yan, Ying Hui ^a   Loh, Horace H ^b   Chen, Hong Zhuan ^a   Law, Ping Yee ^b  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCINEURIN; ETORPHINE; FK 506 BINDING PROTEIN; FK 506 BINDING PROTEIN 12; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MORPHINE; MU OPIATE RECEPTOR; OPRM1 PROTEIN; PROTEIN KINASE C EPSILON; RHODOPSIN; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ARTICLE; CELL STRAIN HEK293; CONTROLLED STUDY; EMBRYO; ENZYME ACTIVATION; GENE MUTATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; RAT; SIGNAL TRANSDUCTION; YEAST;

EID: 84890597813     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.113.087825     Document Type: Article

References (44)

1. Bailey CP, Llorente J, Gabra BH, Smith FL, Dewey WL, Kelly E, and Henderson G (2009) Role of protein kinase C and mu-opioid receptor (MOPr) desensitization in tolerance to morphine in rat locus coeruleus neurons. Eur J Neurosci 29:307-318.
2. Bohn LM, Lefkowitz RJ, and Caron MG (2002) Differential mechanisms of morphine antinociceptive tolerance revealed in (beta)arrestin-2 knock-out mice. J Neurosci 22:10494-10500.
3. Brillantes AB, Ondrias K, Scott A, Kobrinsky E, Ondriasová E, Moschella MC, Jayaraman T, Landers M, Ehrlich BE, and Marks AR (1994) Stabilization of calcium release channel (ryanodine receptor) function by FK506-binding protein. Cell 77:513-523.
4. Cameron AM, Nucifora FC, Jr, Fung ET, Livingston DJ, Aldape RA, Ross CA, and Snyder SH (1997) FKBP12 binds the inositol 1,4,5-trisphosphate receptor at leucine-proline (1400-1401) and anchors calcineurin to this FK506-like domain. J Biol Chem 272:27582-27588.
5. Cameron AM, Steiner JP, Roskams AJ, Ali SM, Ronnett GV, and Snyder SH (1995) Calcineurin associated with the inositol 1,4,5-trisphosphate receptor-FKBP12 complex modulates Ca21 flux. Cell 83:463-472.
6. Cardenas ME, Hemenway C, Muir RS, Ye R, Fiorentino D, and Heitman J (1994) Immunophilins interact with calcineurin in the absence of exogenous immunosuppressive ligands. EMBO J 13:5944-5957.
7. Case DA, Darden TA, Cheatham III TE, Simmerling CL, Wang J, Duke RE, Luo R, Walker RC, Zhang W, Merz KM et al.(2012) AMBER 12, http://ambermd.org/. San Francisco: University of California.
8. Charng MJ, Kinnunen P, Hawker J, Brand T, and Schneider MD (1996) FKBP-12 recognition is dispensable for signal generation by type I transforming growth factor-beta receptors. J Biol Chem 271:22941-22944.
9. Chu J, Zheng H, Loh HH, and Law PY (2008) Morphine-induced mu-opioid receptor rapid desensitization is independent of receptor phosphorylation and beta-arrestins. Cell Signal 20:1616-1624.
10. Chu J, Zheng H, Zhang Y, Loh HH, and Law PY (2010) Agonist-dependent mu-opioid receptor signaling can lead to heterologous desensitization. Cell Signal 22: 684-696.
11. Doll C, Konietzko J, Pöll F, Koch T, Höllt V, and Schulz S (2011) Agonist-selective patterns of m-opioid receptor phosphorylation revealed by phosphosite-specific antibodies. Br J Pharmacol 164:298-307.
12. Duhovny DNR and Wolfson HJ (2002) Efficient unbound docking of rigid molecules, in Algorithms in Bioinformatics: 2nd International Workshop, Proceedings, WABI 2002, Rome, Italy, September 27-21, 2002 (Guigó R and Gusfield D eds) pp 185-200, Springer-Verlag, Berlin.
13. El Kouhen R, Burd AL, Erickson-Herbrandson LJ, Chang CY, Law PY, and Loh HH (2001) Phosphorylation of Ser363, Thr370, and Ser375 residues within the carboxyl tail differentially regulates mu-opioid receptor internalization. J Biol Chem 276: 12774-12780.
14. Gaburjakova M, Gaburjakova J, Reiken S, Huang F, Marx SO, Rosemblit N, and Marks AR (2001) FKBP12 binding modulates ryanodine receptor channel gating. J Biol Chem 276:16931-16935.
15. Giordano A, Romano S, Mallardo M, D'Angelillo A, Calì G, Corcione N, Ferraro P, and Romano MF (2008) FK506 can activate transforming growth factor-beta signalling in vascular smooth muscle cells and promote proliferation. Cardiovasc Res 79:519-526.
16. Huang P, Chen C, Xu W, Yoon SI, Unterwald EM, Pintar JE, Wang Y, Chong PL, and Liu-Chen LY (2008) Brain region-specific N-glycosylation and lipid rafts association of the rat mu opioid receptor. Biochem Biophys Res Commun 365:82-88.
17. Husi H, Luyten MA, and Zurini MG (1994) Mapping of the immunophilinimmunosuppressant site of interaction on calcineurin. J Biol Chem 269: 14199-14204.
18. Just S, Illing S, Trester-Zedlitz M, Lau EK, Kotowski SJ, Miess E, Mann A, Doll C, Trinidad JC, and Burlingame AL et al. (2013) Differentiation of opioid drug effects by hierarchical multi-site phosphorylation. Mol Pharmacol 83:633-639.
19. Kam AY, Liao D, Loh HH, and Law PY (2010) Morphine induces AMPA receptor internalization in primary hippocampal neurons via calcineurin-dependent dephosphorylation of GluR1 subunits. J Neurosci 30:15304-15316.
20. Kerppola TK (2006a) Complementary methods for studies of protein interactions in living cells. Nat Methods 3:969-971.
21. Kerppola TK (2006b) Design and implementation of bimolecular fluorescence complementation (BiFC) assays for the visualization of protein interactions in living cells. Nat Protoc 1:1278-1286.
22. Kieffer BL (1999) Opioids: First lessons from knockout mice. Trends Pharmacol Sci 20:19-26.
23. Liu DM, Katnik C, Stafford M, and Adams DJ (2000) P2Y purinoceptor activation mobilizes intracellular Ca21 and induces a membrane current in rat intracardiac neurones. J Physiol 526:287-298.
24. Liu J, Farmer JD, Jr, Lane WS, Friedman J, Weissman I, and Schreiber SL (1991) Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes. Cell 66:807-815.
25. Marx SO, Reiken S, Hisamatsu Y, Jayaraman T, Burkhoff D, Rosemblit N, and Marks AR (2000) PKA phosphorylation dissociates FKBP12.6 from the calcium release channel (ryanodine receptor): Defective regulation in failing hearts. Cell 101:365-376.
26. Matthes HW, Maldonado R, Simonin F, Valverde O, Slowe S, Kitchen I, Befort K, Dierich A, Le Meur M, and Dollé P et al. (1996) Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the mu-opioidreceptor gene. Nature 383:819-823.
27. McClung CA, Nestler EJ, and Zachariou V (2005) Regulation of gene expression by chronic morphine and morphine withdrawal in the locus ceruleus and ventral tegmental area. J Neurosci 25:6005-6015.
28. Park ST, Aldape RA, Futer O, DeCenzo MT, and Livingston DJ (1992) PPIase catalysis by human FK506-binding protein proceeds through a conformational twist mechanism. J Biol Chem 267:3316-3324.
29. Rezvani A, Huidobro-Toro JP, Hu J, and Way EL (1983) A rapid and simple method for the quantitative determination of tolerance development to opiates in the guinea-pig ileum in vitro. J Pharmacol Exp Ther 225:251-255.
30. Roy A, Kucukural A, and Zhang Y (2010) I-TASSER: A unified platform for automated protein structure and function prediction. Nat Protoc 5:725-738.
31. Roy A, Yang J, and Zhang Y (2012) COFACTOR: An accurate comparative algorithm for structure-based protein function annotation. Nucleic Acids Res 40:W471-W477 DOI: 10.1093/nar/gks372.
32. Schneidman-Duhovny D, Inbar Y, Nussinov R, and Wolfson HJ (2005) PatchDock and SymmDock: Servers for rigid and symmetric docking. Nucleic Acids Res 33: W363-W367 DOI: 10.1093/nar/gki481.
33. Smith FL, Javed R, Elzey MJ, Welch SP, Selley D, Sim-Selley L, and Dewey WL (2002) Prolonged reversal of morphine tolerance with no reversal of dependence by protein kinase C inhibitors. Brain Res 958:28-35.
34. Steiner JP, Dawson TM, Fotuhi M, Glatt CE, Snowman AM, Cohen N, and Snyder SH (1992) High brain densities of the immunophilin FKBP colocalized with calcineurin. Nature 358:584-587.
35. Timerman AP, Wiederrecht G, Marcy A, and Fleischer S (1995) Characterization of an exchange reaction between soluble FKBP-12 and the FKBP.ryanodine receptor complex. Modulation by FKBP mutants deficient in peptidyl-prolyl isomerase activity. J Biol Chem 270:2451-2459.
36. Tsui V and Case DA (2000-2001) Theory and applications of the generalized Born solvation model in macromolecular simulations. Biopolymers 56:275-291.
37. Van Acker K, Bultynck G, Rossi D, Sorrentino V, Boens N, Missiaen L, De Smedt H, Parys JB, and Callewaert G (2004) The 12 kDa FK506-binding protein, FKBP12, modulates the Ca21-flux properties of the type-3 ryanodine receptor. J Cell Sci 117: 1129-1137.
38. Vincent F, Duquesnes N, Christov C, Damy T, Samuel JL, and Crozatier B (2006) Dual level of interactions between calcineurin and PKC-epsilon in cardiomyocyte stretch. Cardiovasc Res 71:97-107.
39. Wang T, Li BY, Danielson PD, Shah PC, Rockwell S, Lechleider RJ, Martin J, Manganaro T, and Donahoe PK (1996) The immunophilin FKBP12 functions as a common inhibitor of the TGF beta family type I receptors. Cell 86: 435-444.
40. Whistler JL, Chuang HH, Chu P, Jan LY, and von Zastrow M (1999) Functional dissociation of mu opioid receptor signaling and endocytosis: Implications for the biology of opiate tolerance and addiction. Neuron 23:737-746.
41. Zhang Y (2008) I-TASSER server for protein 3D structure prediction. BMC Bioinformatics 9:40.
42. Zheng H, Chu J, Qiu Y, Loh HH, and Law P-Y (2008a) Agonist-selective signaling is determined by the receptor location within the membrane domains. Proc Natl Acad Sci USA 105:9421-9426.
43. Zheng H, Chu J, Zhang Y, Loh HH, and Law PY (2011) Modulating micro-opioid receptor phosphorylation switches agonist-dependent signaling as reflected in PKCepsilon activation and dendritic spine stability. J Biol Chem 286: 12724-12733.
44. Zheng H, Loh HH, and Law P-Y (2008b) Beta-arrestin-dependent mu-opioid receptor-activated extracellular signal-regulated kinases (ERKs) Translocate to Nucleus in Contrast to G protein-dependent ERK activation. Mol Pharmacol 73: 178-190.